Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Appendix B: Panel Roster and Financial Disclosures


Last Updated: September 1, 2014; Last Reviewed: September 1, 2014

Pneumocystis Pneumonia
Member Financial Disclosure
Company Relationship
Crothers, Kristina Yale University School of Medicine NIH Research
Furrer, Hansjakob  Universitatsspital Bern, Switzerland None N/A
Helweg-Larsen, Jannik  Rigshospitalet, Copenhagen University, Denmark None N/A
Huang, Laurence University of California, San Francisco NIH Research
Kovacs, Joe*  National Institutes of Health None N/A
Miller, Robert
University College London, England
Gilead Honoraria, Speaker's Bureau
Janssen-Cilag Honoraria, Speaker's Bureau
Mark Allen Healthcare Honoraria
Merck Honoraria, Speaker's Bureau
Morris, Alison
University of Pittsburgh Medical School
Associates of Cape Cod Research Support
Gilead Research Support
NIH Research Support
Roche Research Support
* Group Lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from September 1, 2012, through September 1, 2014.

Download Guidelines